Asthika Goonewardene
Stock Analyst at Truist Securities
(2.05)
# 1,580
Out of 4,502 analysts
70
Total ratings
37.5%
Success rate
-5.48%
Average return
Main Sectors:
Top Industries:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Maintains: Buy | $50 → $44 | $14.98 | +193.72% | 1 | Jun 24, 2024 | |
| ACLX Arcellx | Maintains: Buy | $87 | $62.69 | +38.78% | 4 | Jun 18, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $88 | $59.14 | +48.80% | 1 | Jun 17, 2024 | |
| GMAB Genmab | Maintains: Buy | $50 → $53 | $28.13 | +88.41% | 10 | Jun 4, 2024 | |
| MRUS Merus | Maintains: Buy | $69 → $88 | $54.32 | +62.00% | 2 | Jun 4, 2024 | |
| CGEN Compugen | Maintains: Buy | $5 → $4 | $1.76 | +127.27% | 5 | May 21, 2024 | |
| CRBU Caribou Biosciences | Maintains: Buy | $19 | $2.44 | +678.69% | 3 | May 16, 2024 | |
| CRGX CARGO Therapeutics | Reiterates: Buy | $34 → $32 | $17.70 | +80.79% | 2 | May 16, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $17 | $2.91 | +484.19% | 4 | May 15, 2024 | |
| STRO Sutro Biopharma | Maintains: Buy | $25 → $18 | $4.29 | +320.07% | 5 | Apr 3, 2024 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $17 → $26 | $9.43 | +175.72% | 5 | Mar 7, 2024 | |
| MRSN Mersana Therapeutics | Upgrades: Buy | $9 | $1.98 | +354.55% | 3 | Feb 29, 2024 | |
| EXEL Exelixis | Reiterates: Buy | $32 | $22.96 | +39.37% | 3 | Sep 13, 2023 | |
| IGMS IGM Biosciences | Reiterates: Buy | $25 | $12.10 | +106.61% | 5 | Sep 6, 2023 | |
| HOOK HOOKIPA Pharma | Reiterates: Buy | $40 | $6.32 | +532.91% | 4 | Sep 6, 2023 | |
| ACET Adicet Bio | Reiterates: Buy | $27 | $1.51 | +1,688.08% | 2 | Sep 6, 2023 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $6 → $9 | $4.60 | +95.65% | 3 | Aug 17, 2023 | |
| TIL Instil Bio | Reinstates: Hold | $120 | $12.67 | +847.12% | 1 | Apr 5, 2023 | |
| CELU Celularity | Maintains: Hold | $100 → $60 | $2.99 | +1,906.69% | 3 | Aug 23, 2022 | |
| NXTC NextCure | Maintains: Buy | $19 → $15 | $1.58 | +849.37% | 4 | Aug 23, 2022 |
Arcus Biosciences
Jun 24, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $14.98
Upside: +193.72%
Arcellx
Jun 18, 2024
Maintains: Buy
Price Target: $87
Current: $62.69
Upside: +38.78%
Legend Biotech
Jun 17, 2024
Initiates: Buy
Price Target: $88
Current: $59.14
Upside: +48.80%
Genmab
Jun 4, 2024
Maintains: Buy
Price Target: $50 → $53
Current: $28.13
Upside: +88.41%
Merus
Jun 4, 2024
Maintains: Buy
Price Target: $69 → $88
Current: $54.32
Upside: +62.00%
Compugen
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.76
Upside: +127.27%
Caribou Biosciences
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $2.44
Upside: +678.69%
CARGO Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $34 → $32
Current: $17.70
Upside: +80.79%
Allogene Therapeutics
May 15, 2024
Maintains: Buy
Price Target: $17
Current: $2.91
Upside: +484.19%
Sutro Biopharma
Apr 3, 2024
Maintains: Buy
Price Target: $25 → $18
Current: $4.29
Upside: +320.07%
Iovance Biotherapeutics
Mar 7, 2024
Maintains: Buy
Price Target: $17 → $26
Current: $9.43
Upside: +175.72%
Mersana Therapeutics
Feb 29, 2024
Upgrades: Buy
Price Target: $9
Current: $1.98
Upside: +354.55%
Exelixis
Sep 13, 2023
Reiterates: Buy
Price Target: $32
Current: $22.96
Upside: +39.37%
IGM Biosciences
Sep 6, 2023
Reiterates: Buy
Price Target: $25
Current: $12.10
Upside: +106.61%
HOOKIPA Pharma
Sep 6, 2023
Reiterates: Buy
Price Target: $40
Current: $6.32
Upside: +532.91%
Adicet Bio
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $1.51
Upside: +1,688.08%
Autolus Therapeutics
Aug 17, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $4.60
Upside: +95.65%
Instil Bio
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $12.67
Upside: +847.12%
Celularity
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $2.99
Upside: +1,906.69%
NextCure
Aug 23, 2022
Maintains: Buy
Price Target: $19 → $15
Current: $1.58
Upside: +849.37%